Durability of Early Combination Therapy vs Conventional Therapy in New Onset T2DM

Project: Research project

Project Details


? DESCRIPTION (provided by applicant): Hyperglycemia is the major risk factor for the development of diabetic microvascular complications. The ADA recommends lowering the A1c in T2DM individuals to levels (i.e. HbA1c
Effective start/end date9/1/158/31/18


  • National Institutes of Health: $479,984.00


  • Medicine(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.